Acorus calamus Exhibiting Antidiabetic Activity: An in vitro and in silico Approach

ABSTRACT

Background: Diabetes mellitus is a multifaceted metabolic disorder characterized by chronically elevated blood glucose levels. Existing therapeutic strategies often present limitations such as adverse toxicity and the emergence of drug resistance, necessitating the search for safer and more effective alternatives. Aim and Objectives:The present study aimed to evaluate the antidiabetic potential of natural compounds derived from Acorus calamus through in vitro α-amylase inhibition and in silico molecular docking approaches targeting key diabetic protein receptors. Materials and Methods: A total of 12 natural compounds extracted from Acorus calamus were subjected to α-amylase inhibition assays to assess their in vitro antidiabetic activity. Additionally, molecular docking studies were performed using AutoDock Vina against two key protein targets, PDB IDs: 1XU7 and 3C45. Toxicity prediction, drug-likeness, and pharmacokinetic properties were analyzed using SwissADME and ProTox-II platforms. Molecular dynamics simulations were conducted using the iMODS server. Results:The Acorus calamus extract demonstrated a superior α-amylase inhibitory activity with an IC₅₀ value of 2.87±0.38 mg/mL, outperforming the standard drug metformin (3.25±0.47 mg/mL). Among the 12 tested compounds, Galgravin exhibited the highest binding affinities for both 1XU7 (-8.5 kcal/mol) and 3C45 (-7.7 kcal/mol), surpassing those of metformin (-7.3 kcal/mol and -6.7 kcal/mol, respectively). Galgravin also showed the lowest predicted toxicity, highest LD₅₀ values, favorable drug-likeness, and excellent bioavailability. Molecular dynamics studies further confirmed its stable interaction and favorable dynamic behavior. Conclusion: The findings highlight Galgravin, a compound from Acorus calamus, as a promising natural inhibitor of key diabetic targets, potentially surpassing metformin in efficacy and safety. These results advocate further in vivo and clinical evaluations to validate its therapeutic potential in diabetes management.

KEYWORDS

• α-Amylase assay
• Molecular Docking
• ADME Studies
• Toxicity Prediction
• Molecular Dynamics

Showing references and in-text citations exactly as published.

• DOI10.5530/ajbls.20250022Copy

RELATED ARTICLES

Matched on section and article type within this issue of AJBLS.

• Article · VOLUME 14, ISSUE 3Identification of Bioactive Compounds in Meha Mudgara Rasa Using Gas Chromatography-Mass Spectrometry (GC-MS): Implications in Diabetic NeuropathyShailesh Deshpande, Meha Gandhi · pp. 574–585Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 3Assessment of Effect of Comorbidities on Quality of Life of Pancreatitis Patients Using SF36V1Nukabathini Jessica, Danthala Srujana, Mehedi Hasan, Mohd Azharuddin, M. Chinnaeswaraiah · pp. 586–592Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 3Antibacterial Properties of Cow Urine Collected from a Badri CalfMansi Arya, Shikha Bora, Nagma Parveen, Deepak Chandra Melkani, Gaurav Rawat, Netra Pal Sharma, Satpal Singh Bisht · pp. 593–597Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 3Evaluation of the Anthelmintic Potential of Pongamia pinnata Root Hydroalcoholic Extract against Tubifex tubifexShaon Dey, Kousik Saha, Urmistha Sarkar, Krishanu Pramanick, Sanjib Manna, Riju Koley, Santanu Manna, Priya Roy · pp. 598–602Original ArticleSame type: Article